Biotech Investors & VC Firms in United Kingdom
294 firms in this list, with a median first check of $500K. 62 of them lead rounds. Generated from verified public data and updated continuously.
Korys
HalleSeries A–Late Stage$5.4M
40 people
Taiwania Capital
TaipeiSeed–Growth$3M – $85M
46 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
42 people
b2venture
BerlinPre-Seed–Late Stage$270K – $5.4M
36 people
HEALTHCARE ROYALTY PARTNERS
New York
29 people
Oxford Finance LLC
AlexandriaSeed–Late Stage$5M – $125M
45 people
SR One Capital Management
Redwood CitySeed–Series B
32 people
HealthCap
StockholmSeed–Growth
34 people
Extantia Capital
BerlinPre-Seed–Series A$1.1M – $5.5M
25 people
Blume Ventures
MumbaiSeed–Late Stage$650K – $36M
21 people
UntroD Capital
TokyoPre-Seed–Growth$772K – $241M
5 people
TMV
New YorkPre-Seed–Series A$1.5M
14 people
SVG Ventures | THRIVE
Silicon ValleyPre-Seed–Series A$10K – $100K
30 people
M Ventures
Los AngelesSeed–Growth$10.8M
6 people
Nina Capital
BarcelonaPre-Seed–Series A$215K – $1.6M
18 people
Panacea Venture
SingaporePre-Seed–Late Stage
22 people
Trendlines Group
MisgavPre-Seed–Late Stage$650K – $15M
18 people
Samsung Ventures
SeoulSeed–Late Stage
26 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $55M
24 people
Metavallon VC
AthensPre-Seed–Series A$220K – $1.6M
11 people
European Circular Bioeconomy Fund
BonnSeries A–Late Stage$5.5M – $16.5M
23 people
Fly Ventures
BerlinPre-Seed–Series A$1.1M – $4.3M
6 people
T. Rowe Price
BaltimoreSeed–Late Stage
1 person
Apollo Health Ventures
BerlinSeed–Series A
29 people
Related lists
Investors & VC Firms in North America (14143)Investors & VC Firms in United States (13281)Investors & VC Firms in Europe (5575)Crypto & Web3 Investors & VC Firms (4830)Investors & VC Firms in Global (4158)SaaS Investors & VC Firms (3865)AI & Machine Learning Investors & VC Firms (3769)Fintech Investors & VC Firms (3726)Investors & VC Firms in Asia-Pacific (3574)Healthtech Investors & VC Firms (3415)
Data sourced from public filings and firms' own websites — see our methodology.









































































































